학술논문
The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.
Document Type
Journal Article
Author
Source
Subject
*BREAST cancer
*UROKINASE
*PLASMINOGEN activators
*CARBONIC anhydrase
*CANCER chemotherapy
*ANTINEOPLASTIC agents
*ANTHRACYCLINES
*BREAST tumors
*CELL receptors
*COMBINED modality therapy
*DOXORUBICIN
*FLUOROURACIL
*LONGITUDINAL method
*PROGNOSIS
*SURVIVAL
*TUMOR antigens
*CASE-control method
*CYCLOPHOSPHAMIDE
*EPIRUBICIN
*BLOOD
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0973-1482
Abstract